Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Hepatitis B virus (HBV) infection and multiple sclerosis: One more reason to undergo vaccination?
The importance of IL-33 in allergic inflammation.
[Vaccines and central nervous system demyelinating diseases: New studies on the internet –not just new rumors].
Increased multiple sclerosis relapses related to lower prevalence of pain.
Magnetic resonance imaging of the cervical spinal cord in multiple sclerosis at 7T.
Cortical lesions in multiple sclerosis: inflammation versus neurodegeneration.
Targeting Potassium Channels Kv1.3 and KC a 3.1: Routes to Selective Immunomodulators in Autoimmune Disorder Treatment?
Dopaminergic D2-like agonists produce yawning in the myelin mutant taiep and Sprague-Dawley rats.
Quality of life and coping strategies in Lebanese Multiple Sclerosis patients: A pilot study.
Cognitive Reserve as a Useful Concept for Early Intervention Research in Multiple Sclerosis.
Abnormal distribution of AQP5 in labial salivary glands is associated with poor saliva secretion in patients with Sjögren's syndrome including neuromyelitis optica complicated patients.
Berberine and neurodegeneration: A review of literature.
Coculture of Primary Motor Neurons and Schwann Cells as a Model for In Vitro Myelination.
L-periaxin interacts with S-periaxin through its PDZ domain.
Do coping styles mediate the relationship between disability status and psychosocial loss in people with relapsing remitting multiple sclerosis?
Heme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin.
Internal tremor in Parkinson's disease, multiple sclerosis, and essential tremor.
Neuropharmacological Actions of Metformin in Stroke.
Neuroprotection and immunomodulation by xenografted human mesenchymal stem cells following spinal cord ventral root avulsion.
Comparison of Intelligibility Measures for Adults with Parkinson's Disease, Multiple Sclerosis and Healthy Controls.
Biochemical Pharmacology of the Sigma-1 Receptor.
The established and emerging roles of astrocytes and microglia in amyotrophic lateral sclerosis and frontotemporal dementia.
Placebo controlled trials in neuromyelitis optica are needed and ethical.
Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatment.
New EMA Advice for PML Prevention With Fingolimod in MS

Pages